Hydrostasis Selected as a Top 4 NIH-NHLBI SBIR Company at ACC Innovation Challenge
April 2022

WASHINGTON D.C., April 2022 -- Hydrostasis was honored to be one of the top four NIH-NHLBI SBIR awardees invited to present at the 2022 American College of Cardiology (ACC.22) Annual Meeting.

Our presentation was featured in the Future Hub, a showcase dedicated to the future of health technology and innovation. This dynamic space is designed to inform, educate, and inspire ACC.22 attendees by highlighting cutting-edge advancements in Digital Health, Medical Devices, and Educational Technology.

We’re proud to be recognized for our work in personalized hydration monitoring and to contribute to the conversation on next-generation solutions for cardiovascular care and beyond.

More from our blog
A Surreal Moment at CES 2026
CES has a way of compressing years of work into a single moment.
Hydrostasis Heads to CES 2026
Hydrostasis is kicking off the new year at CES 2026
GECA Watch 2.0 Is Live
We just went live with GECA Watch 2.0.
Inside Our IV Hydration Research Study with GECA Watch 2.0
A few weeks ago, we completed a hands-on research study with ASAP IVs, putting GECA Watch 2.0 to the test in a real clinical setting.
Taking GECA Watch 2.0 Into the Real World
This past weekend, we took GECA Watch 2.0 out of the lab and into the real world during a research study hosted at ASAP IVs
A Sneak Peek at GECA Watch 2.0: San Diego Event Recap
This past weekend, we opened the doors in Encinitas for a first look at GECA Watch 2.0, and San Diego showed up.